Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | NAMPT | P43490 | 1/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31468266 | 1.00 | CA2 (0.39) | CA2EPHX2TSHRALDH1A1NAMPT | |
| SCHEMBL4512963 | 1.00 | CA2 (0.39) | CA2EPHX2TSHRALDH1A1NAMPT | |
| SCHEMBL31468267 | 1.00 | CA2 (0.39) | CA2EPHX2TSHRALDH1A1NAMPT | |
| SCHEMBL31468271 | 1.00 | CA2 (0.39) | CA2EPHX2TSHRALDH1A1NAMPT | |
| SCHEMBL232929 | 1.00 | CA2 (0.39) | CA2EPHX2TSHRALDH1A1NAMPT | |
| SCHEMBL5556018 | 1.00 | CA2 (0.39) | CA2EPHX2TSHRALDH1A1NAMPT | |
| SCHEMBL23451307 | 1.00 | CA2 (0.39) | CA2EPHX2TSHRALDH1A1NAMPT | |
| SCHEMBL221314 | 0.98 | — | — | |
| SCHEMBL11571033 | 0.94 | EPHX2 (0.37) | CA2EPHX2TSHRALDH1A1NAMPT | |
| SCHEMBL871278 | 0.87 | MEN1 (0.35) | TSHRALDH1A1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025064681-A1 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | ENTASIS THERAPEUTICS INC. (US) | 2025-03-27 | — | — | WO | disclosed |